Delivery Order SPE2DB22D2108-SPE2DB25FU5PE
- Not listed
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. This firm fixed-price delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a small-value pharmaceutical procurement issued under a non-competitive set-aside arrangement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a commonly prescribed anticoagulant medication, valued at $3,931.20. This non-set-aside contract was awarded competitively on June 2, 2025, with an ultimate completion date of June 3, 2025, utilizing firm fixed pricing. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This non-competitive delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, operates under a firm fixed-price arrangement and represents a single-line pharmaceutical procurement to support federal medical supply needs. The award is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $22,144.15 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a pharmaceutical product commonly used for anticoagulation therapy. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded under open procurement procedures. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,915.94 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely-prescribed anticoagulant medication. Issued on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,064.70 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This firm fixed price delivery order, awarded on June 17, 2025, with completion scheduled for June 18, 2025, represents a routine pharmaceutical procurement through the federal medical supply chain. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office located in...
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract utilizes no set-aside designation and was competitively awarded. Performance will...
- The Defense Logistics Agency awarded a $11,944.06 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. Awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside delivery order. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5PEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. The contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The pharmaceutical supply arrangement reflects the Defense Logistics Agency's medical supply chain operations, which leverage indefinite delivery vehicles to maintain flexible procurement capabilities for critical medications needed across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/22/25 |